Intra-articular enzyme replacement therapy with rhIDUA is safe, well-tolerated, and reduces articular GAG storage in the canine model of mucopolysaccharidosis type I. Treatment with intravenous enzyme replacement therapy and hematopoietic stem cell transplantation for mucopolysaccharidosis type I does not address joint disease, resulting in ... (more)
http://ift.tt/1mwLrQy
http://ift.tt/1mwLrQy
No comments:
Post a Comment